About
Cardionomic is developing a transformative, neuromodulation treatment to address a large unmet need for patients suffering from acute decompensated heart failure (ADHF). The company's catheter-based Cardiac Pulmonary Nerve Stimulation (CPNS) System electrically stimulates the autonomic cardiac nerves to increase contractility of the heart. Cardionomic has successfully demonstrated human feasibility of the physiological mechanism behind its device in multiple investigational clinical studies.
Technologies
Outlook
Amazon AWS
Remote
AI
Keywords
medical equipment manufacturing
medical devices
hospital & health care
Company Information
-
Employees 4
-
Founded 2015
-
Annual Revenue $4420000
-
Total Funding $44799998
Location
601 Campus Dr, New Brighton, Minnesota, United States, 55112
